Therapeutic KRAS <sup>G12C</sup> inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers

Edurne Mugarza(Vall d'Hebron Institut de Recerca), Julian Downward(The Francis Crick Institute)
Science Advances
July 20, 2022
Cited by 134


Related Papers